ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 69 filers reported holding ARCELLX INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,097,396 | +19.6% | 392,904 | +5.4% | 0.03% | +23.1% |
Q2 2023 | $11,791,224 | +1.5% | 372,904 | -1.1% | 0.03% | 0.0% |
Q1 2023 | $11,612,412 | -12.2% | 376,904 | -11.7% | 0.03% | -18.8% |
Q4 2022 | $13,225,486 | +33.7% | 426,904 | -19.0% | 0.03% | +28.0% |
Q3 2022 | $9,890,000 | +3.8% | 526,904 | 0.0% | 0.02% | +13.6% |
Q2 2022 | $9,526,000 | -26.8% | 526,904 | -43.2% | 0.02% | -12.0% |
Q1 2022 | $13,005,000 | – | 927,568 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $170,390,217 | 62.20% |
PATHWAY CAPITAL MANAGEMENT, LP | 189,120 | $5,858,938 | 10.46% |
NEA Management Company, LLC | 4,745,262 | $147,008,217 | 8.26% |
Samsara BioCapital, LLC | 957,451 | $29,661,832 | 6.38% |
Soleus Capital Management, L.P. | 1,102,447 | $34,153,808 | 4.90% |
Cormorant Asset Management, LP | 2,075,000 | $64,284 | 4.30% |
Paradigm Biocapital Advisors LP | 882,101 | $27,327,489 | 3.21% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,350,333 | $72,813,316 | 3.06% |
Affinity Asset Advisors, LLC | 240,143 | $7,439,630 | 2.92% |
CAXTON CORP | 36,302 | $1,124,640 | 2.87% |